Status | Study |
Terminated |
Study Name: UVA1 Light for Scleroderma and Similar Conditions Condition: Keloid Scleroderma Scars Date: 2007-05-18 Interventions: Device: German manufactured UVA1 emitting light system The dose and scheduling of irradiation is as foll |
Completed |
Study Name: UVA1 Light for Treatment of Scleroderma and Similar Conditions Condition: Scleroderma Keloids Other Fibrosing Conditions Date: 2007-05-18 Interventions: Device: German manufactured UVA1 light emitting device The UVA1 dose will be up to 130 J/cm2. |
Withdrawn |
Study Name: Imiquimod 5% Cream in Plaque-type Morphea: A Pilot, Prospective Open-label Study Condition: Morphea Date: 2005-09-28 Interventions: Drug: imiquimod 5% cream (Aldara) |
Completed |
Study Name: Imiquimod in Children With Plaque Morphea Condition: Scleroderma, Localized Date: 2005-09-02 Interventions: Drug: Imiquimod 5% cream Treatment will last for 36 weeks. Patients will be instructed to apply Imiquimo |